Dgci
-
{
- All
- News
- Videos
-
Covid Vaccines Being "Analysed Aggressively", Says Minister Amid Key Meet
Applications for the emergency use approval for the coronavirus vaccines filed by the Serum Institute of India, Bharat Biotech and Pfizer are being taken up once again for consideration by a government-appointed panel of experts today.
-
Biocon gets approval to market anti-psoriasis drug
Biotechnology major Biocon today said it has received approval from Drug Controller General of India (DCGI) to market its product 'Itolizumab', used in the treatment of psoriasis.
-
Glenmark gets DCGI nod for phase III trials of diarrhoea drug
Napo Pharmaceuticals Inc, however, had recently claimed terminating an agreement signed in July 2005 with Glenmark regarding Crofelemer.
-
Covid Vaccines Being "Analysed Aggressively", Says Minister Amid Key Meet
Applications for the emergency use approval for the coronavirus vaccines filed by the Serum Institute of India, Bharat Biotech and Pfizer are being taken up once again for consideration by a government-appointed panel of experts today.
-
Biocon gets approval to market anti-psoriasis drug
Biotechnology major Biocon today said it has received approval from Drug Controller General of India (DCGI) to market its product 'Itolizumab', used in the treatment of psoriasis.
-
Glenmark gets DCGI nod for phase III trials of diarrhoea drug
Napo Pharmaceuticals Inc, however, had recently claimed terminating an agreement signed in July 2005 with Glenmark regarding Crofelemer.
